Aptevo

$25.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.54 (-2.09%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Aptevo and other stocks, options, and ETFs commission-free!

About APVO

Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer.

CEO
Marvin L. White
Employees
58
Headquarters
Seattle, Washington
Founded
2016
Market Cap
108.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
42.18K
High Today
$26.70
Low Today
$24.00
Open Price
$26.00
Volume
24.88K
52 Week High
$60.00
52 Week Low
$3.44

APVO Earnings

-$2.41
-$1.61
-$0.80
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

TRTN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure